4//SEC Filing
O'Day Daniel Patrick 4
Accession 0001127602-25-018401
CIK 0000882095other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 6:02 PM ET
Size
6.7 KB
Accession
0001127602-25-018401
Insider Transaction Report
Form 4
O'Day Daniel Patrick
DirectorChairman & CEO
Transactions
- Sale
Common Stock
2025-06-30$110.40/sh−9,400$1,037,796→ 616,325 total - Sale
Common Stock
2025-06-30$111.15/sh−600$66,688→ 615,725 total
Footnotes (3)
- [F1]The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025.
- [F2]Sale prices reported for the transactions reported here range from $110.03 to $111.00. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- [F3]Sale prices reported for the transactions reported here range from $111.03 to $111.17. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Documents
Issuer
GILEAD SCIENCES, INC.
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001638643
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 6:02 PM ET
- Size
- 6.7 KB